Sacubitril Sodium API Market was valued at USD 0.95 Billion in 2022 and is projected to reach USD 2.00 Billion by 2030, growing at a CAGR of 10.1% from 2024 to 2030.
Looking forward, the demand for Sacubitril Sodium API from 2023 to 2033 is expected to accelerate. A rising global incidence of heart disease, aging populations in developed countries, and a growing emphasis on preventative healthcare are driving factors. In addition, advancements in drug formulations and delivery systems are anticipated to enhance the efficacy of Sacubitril-based medications, further expanding their adoption across diverse patient populations. With clinical trials showing consistent benefits, new entrants into the market are expected, boosting competition and further innovating treatments. The market for Sacubitril Sodium API is expected to grow at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2033.
In emerging markets, a shift towards better healthcare provision and increasing disposable incomes are also factors contributing to the steady rise in demand. The adoption of Sacubitril Sodium API will likely increase as healthcare systems adopt more specialized treatment regimens for chronic conditions. In particular, countries in Asia-Pacific and Latin America are expected to witness rapid growth in demand for heart failure drugs, with Sacubitril-based products leading the charge due to their proven efficacy in improving patient outcomes.
Get an In-Depth Research Analysis of the Global Sacubitril Sodium API Market Size And Forecast [2025-2032]
The Sacubitril Sodium API (Active Pharmaceutical Ingredient) market has experienced notable developments between 2018 and 2022, and these shifts provide valuable insights into the future demand projections from 2023 to 2033. Sacubitril sodium, a key component in the production of Entresto, is primarily used in the treatment of heart failure. With its potential to improve patient outcomes significantly, the market demand for Sacubitril Sodium API has surged, primarily driven by growing awareness of heart diseases and advancements in cardiovascular treatments.
From 2018 to 2022, the Sacubitril Sodium API market witnessed considerable growth due to a rise in the number of heart failure patients globally. Healthcare infrastructure improvements, especially in emerging markets, supported increased access to Sacubitril-based treatments. The market was also impacted by regulatory approvals and collaborations between pharmaceutical companies. As the demand for heart failure therapies continued to rise, Sacubitril Sodium API became an essential product for leading drug manufacturers. The market was valued at USD 450 million in 2020 and has consistently shown growth despite the challenges posed by the pandemic.
Raks Pharma
Mankind Pharma
Zhuhai Rundu Pharmaceutical Co.
Ltd
Zhejiang Hengkang Pharmaceutical
Amino Chemicals
Pharmirae Co.
Ltd.
Shenzhen Salubris Pharmaceuticals Co.
Ltd.
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Sacubitril Sodium API Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Sacubitril Sodium API Market
Tablets
Others
Based on Types the Market is categorized into Below types that held the largest Sacubitril Sodium API market share In 2023.
Above 98 %
Above 99 %
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Sacubitril Sodium API Market Research Analysis
1. Introduction of the Global Sacubitril Sodium API Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Sacubitril Sodium API Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Sacubitril Sodium API Market, By Type
6. Global Sacubitril Sodium API Market, By Application
7. Global Sacubitril Sodium API Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Sacubitril Sodium API Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/